UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGD
3801
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$526M
| $1.37M | ﹤0.01% |
233,900
+36,813
| +19% | +$218K |
|
3802
Trustmark
TRMK
$2.8B
| $1.37M | ﹤0.01% |
45,049
-15,402
| -25% | -$499K |
|
3803
Everspin Technologies
MRAM
$410M
| $1.37M | ﹤0.01% |
156,977
-4,775
| -3% | -$45.7K |
|
3804
PUT
Coeur Mining
CDE
$19B
| $1.37M | ﹤0.01% |
307,000
+97,000
| +46% | +$462K |
|
|
SA
3805
Seabridge Gold
SA
$3.46B
| $1.36M | ﹤0.01% |
73,763
-93,071
| -56% | -$1.58M |
|
3806
PUT
Yelp
YELP
$1.32B
| $1.36M | ﹤0.01% |
40,000
+20,000
| +100% | +$687K |
|
3807
Arcosa
ACA
$7.12B
| $1.36M | ﹤0.01% |
23,778
-8,474
| -26% | -$437K |
|
3808
HUB Group
HUBG
$2.55B
| $1.36M | ﹤0.01% |
35,234
-21,390
| -38% | -$855K |
|
3809
Nuveen Core Equity Alpha Fund
JCE
$293M
| $1.36M | ﹤0.01% |
77,458
+3,815
| +5% | +$62.4K |
|
3810
State Street SPDR S&P Capital Markets ETF
KCE
$484M
| $1.36M | ﹤0.01% |
14,862
-9,698
| -39% | -$911K |
|
|
PHK
3811
PIMCO High Income Fund
PHK
$865M
| $1.36M | ﹤0.01% |
234,965
+12,113
| +5% | +$71.5K |
|
|
UCTT
3812
Ultra Clean Holdings
UCTT
$4.21B
| $1.35M | ﹤0.01% |
31,857
+7,598
| +31% | +$364K |
|
3813
BILL Holdings
BILL
$5.11B
| $1.35M | ﹤0.01% |
5,942
-828
| -12% | -$173K |
|
3814
CALL
Establishment Labs
ESTA
$2.25B
| $1.35M | ﹤0.01% |
+20,000
| New | +$1.17M |
|
3815
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.82B
| $1.35M | ﹤0.01% |
25,945
-3,635
| -12% | -$189K |
|
3816
Invesco DB Precious Metals Fund
DBP
$256M
| $1.35M | ﹤0.01% |
25,985
+23,367
| +893% | +$1.18M |
|
3817
Coherus Oncology
CHRS
$176M
| $1.34M | ﹤0.01% |
103,861
-59,831
| -37% | -$761K |
|
|
FFC
3818
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$781M
| $1.34M | ﹤0.01% |
68,006
-10,093
| -13% | -$201K |
|
3819
Heron Therapeutics
HRTX
$63.5M
| $1.34M | ﹤0.01% |
234,120
-85,137
| -27% | -$623K |
|
|
EGRX
3820
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.34M | ﹤0.01% |
27,064
-6,648
| -20% | -$319K |
|
3821
Agios Pharmaceuticals
AGIO
$2B
| $1.34M | ﹤0.01% |
45,863
-139,562
| -75% | -$4.26M |
|
3822
National Beverage
FIZZ
$2.93B
| $1.33M | ﹤0.01% |
30,602
+8,956
| +41% | +$389K |
|
3823
Dine Brands
DIN
$440M
| $1.33M | ﹤0.01% |
17,080
-8,941
| -34% | -$665K |
|
3824
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.23B
| $1.33M | ﹤0.01% |
9,259
+364
| +4% | +$51K |
|
3825
Calumet Specialty Products
CLMT
$4.29B
| $1.33M | ﹤0.01% |
97,580
+3,211
| +3% | +$47.3K |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.